MC2 Therapeutics to present at BIO CEO & Investor Conference 2023
POSTED: January 31, 2023
Copenhagen, January 31st, 2023 – MC2 Therapeutics A/S, a commercial stage pharmaceutical company, engaged in research in skin biology and development of novel treatment paradigms for autoimmune and chronic inflammatory ...
READ FULL ARTICLE >